Tetrabenazine

 
0.0 (0)
This page displays reviews written by users of all forms of Tetrabenazine. You can also choose to see reviews only for a specific medical condition or brand name.
Brand Names
Medical Conditions

More about Tetrabenazine

What is/are Tetrabenazine?

etrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorder and is marketed under the trade names Nitoman in Canada and Xenazine in New Zealand and some parts of Europe, and is also available in the USA as an orphan drug. On August 15, 2008 the U.S. Food and Drug Administration (FDA) approved the use of tetrabenazine to treat chorea associated with Huntington's disease (HD), the first in the US. The compound has been known since the 1950s. The effort for US FDA approval was led by Dr. Joseph Jankovic. According to a 2008 news report, "Americans with Huntington's who weren't Jankovic's patients ordered tetrabenazine from Canada if they could afford it. But the worsening exchange rate put the price out of reach for many. A recent check found Canadian Internet pharmacies selling generic 25-milligram pills for $1.75 or more each in U.S. currency, brand-name 25-mg pills for around $2.35 each." After the FDA approval, Dr. Jancovic said "I'm worried that the drug is just going to be too expensive" and initial pricing was $68.50 per 25 mg tablet.

Medical uses

Tetrabenazine is used as a treatment, but not a cure for hyperkinetic disorders such as:

  •     Huntington's Disease – specificially the chorea associated with it
  •     Tourette syndrome and other tic disorders
  •     Tardive dyskinesia, a serious and sometimes irreversible side effect of long-term use of many antipsychotics, mainly typical antipsychotics
  •     Hemiballismus, spontaneous flinging limb movements due to contra-lateral subthalamic nucleus damage

Adverse effects

Because tetrabenazine is closely related to antipsychotics, many of its side effects are similar. Some of these include:

  •     Akathisia (aka "restless pacing" – an inability to keep still, with intense anxiety when forced to do so)
  •     Depression - the most common side effect, reported in roughly 15% of those who take the medication
  •     Dizziness, drowsiness, insomnia, fatigue, nervousness and anxiety
  •     Parkinsonism

Unlike many antipsychotics, tetrabenazine is not known to cause tardive dyskinesia.

This article uses material from the Wikipedia article Tetrabenazine, which is released under the Creative Commons Attribution-Share-Alike License 3.0.

Reviews for Tetrabenazine

See reviews for a different combination of brand names and medical conditions:
     
There are no user reviews for this listing.
Already have an account?
Ratings
Overall satisfaction
Efficacy
Lack of side effects
Relevant Brand Name and Medical Condition
Additional Information
Please tell us about your experience with this medicine